First AD

Second AD

Dr Voss Application of Updated KEYNOTE-564 Data

Clinical

® Clinical Focus page includes a listing of all specialities covered across  OncLive.com, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, hematologic malignancies, and gynecologic cancers. Each individual specialty page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research.


OncLive Peer Exchange® 

® Peer Exchange video program comprises lively expert panel discussions feature peer-to-peer exchanges providing authoritative insights, opinions, and perspectives on important issues facing today’s health care professionals. Episodes focus on updates and insights across solid and hematologic malignancies, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecological cancers, and hematologic malignancies. 

Video Series

ASCO 2024: Updates in the Treatment of Advanced Renal Cell Carcinoma

Peer Exchange

Final Thoughts/Looking Forward 

Treatment Selection in the Frontline Setting of Advanced Clear Cell RCC    

Dr Wulff-Burchfield Reviews CheckMate 214 and CheckMate 9ER 

Dr Xu Reviews Data from the CLEAR Trial and Recent Analyses at ASCO 2024 - Lenvatinib + Pembrolizumab in Frontline Advanced RCC 

Dr Voss Shares Highlights from the COSMIC-313 and LITESPARK-024 Trials  

Exciting Data and Trials in Progress from ASCO 2024 

Ongoing RCC Clinical Trials that may Impact Practice 

Dr Xu Provides Clinical Perspective on the CONTACT-03 Trial Outcomes 

Dr Voss Application of Updated KEYNOTE-564 Data   

Guiding Sequencing & Finding a Contemporary Regimen/ Approach to Treatment Post-Checkpoint Inhibition 

World Health Organization (WHO) Classification Updates for Papillary RCC

Additional Forward-Looking Data and Studies Beyond Frontline Therapy in RCC 

The Role of Chemotherapy in nccRCC Treatment 

Select Ongoing Trials for nccRCC and Impact on the Treatment Landscape 